Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could gut bugs hold key to childhood asthma?

NCT ID NCT06842836

Knowledge-focused Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study examines whether children with asthma have different gut bacteria compared to healthy children. Researchers will collect stool samples from 20 children aged 6 to 9 with mild asthma. The goal is to understand how gut microbes might influence asthma, which could lead to new insights for future treatments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could reveal links between gut bacteria and asthma in children, pointing toward new ways to prevent or manage the disease.
What could go wrong
This is a very small, early feasibility study with only 20 children. It is designed to gather information, not test a treatment, so it may not lead to direct health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

20 people

The number who actually took part.

Started

May 2024

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Approximately 25 pediatric subjects aged 6 to 9 years, diagnosed with intermittent or mild persistent bronchial asthma, referred to the pediatric outpatient clinic of the Children's Hospital of Alexandria will be enrolled in the study

Ages

6 to 9 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signature of informed consent by Parents; * Age between 6 and 9 years; * Confirmed diagnosis of bronchial asthma at Alessandria Children's Hospital through spirometry investigation; * Bronchial asthma classified as intermittent or mild persistent; * Patients followed at the outpatient clinics of the SC Pediatrics of AOU SS Antonio e Biagio and C. Arrigo of Alessandria. Exclusion Criteria: * Taking prolonged systemic therapy for the treatment of bronchial asthma; * Bronchial asthma classified as moderate persistent or severe persistent; * Insurmountable language barrier. * Ongoing antibiotic intake.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma bronchiale are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma bronchiale

Contacts and locations

Locations

  • SSD Laboratori di Ricerca (DAIRI) - AOU Alessandria

    Alessandria, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.